SCHEMBL7503365

SCHEMBL7503365

NS(=O)(=O)c1ccc(-c2nc(Cc3ccccc3)oc2-c2cc(Cl)ccc2Cl)cc1

nearest known ligand 0.56

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ RXRA P19793 5/20 0.56
▸ RXRB P28702 5/20 0.56
▸ CA1 P00915 5/20 0.44
▸ CA2 P00918 5/20 0.44
▸ CA12 O43570 2/20 0.44
▸ CA9 Q16790 2/20 0.44
▸ CA14 Q9ULX7 1/20 0.44
▸ NR4A2 P43354 3/20 0.43
▸ MAPT P10636 2/20 0.43
▸ ALDH1A1 P00352 1/20 0.43
▸ LMNA P02545 1/20 0.43
▸ PTGS2 P35354 4/20 0.42
▸ PTGS1 P23219 3/20 0.42
▸ RXRG P48443 3/20 0.41
▸ ENPP3 O14638 1/20 0.41
▸ MAOA P21397 1/20 0.39
▸ MAOB P27338 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7505854 0.92 RXRA (0.46) RXRARXRBCA1CA2CA12
SCHEMBL7509654 0.92 RXRA (0.46) RXRARXRBCA1CA2CA12
SCHEMBL7497030 0.90 RXRA (0.56) RXRARXRBNR4A2MAPTALDH1A1
SCHEMBL7500825 0.89 NR4A2 (0.55) RXRARXRBCA1CA2CA12
SCHEMBL7507947 0.88 LMNA (0.44) RXRARXRBCA1CA2CA12
SCHEMBL7504153 0.87 RXRA (0.53) RXRARXRBCA1CA2CA12
SCHEMBL7505978 0.87 RXRA (0.53) RXRARXRBCA1CA2CA12
SCHEMBL7503126 0.86 RXRA (0.55) RXRARXRBCA1CA2CA12
SCHEMBL7504953 0.86 CA2 (0.44) RXRARXRBCA1CA2CA12
SCHEMBL7499023 0.85 CA2 (0.43) RXRARXRBCA1CA2CA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0699192-B1 SUBSTITUTED OXAZOLYL COMPOUNDS FOR THE TREATMENT OF INFLAMMATION SEARLE & CO (US) 2002-07-24 — — EP disclosed
US-6090834-A ANALGESICS; RHEUMATIC DISORDERS; SKIN DISORDERS; GASTROINTESTINAL DISORDERS G.D. SEARLE & CO. (US) 2000-07-18 — — US disclosed
EP-0825989-A1 SUBSTITUTED OXAZOLES FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1998-03-04 — — EP disclosed
WO-1996036617-A1 SUBSTITUTED OXAZOLES FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1996-11-21 — — WO disclosed
EP-0699192-A1 SUBSTITUTED OXAZOLYL COMPOUNDS FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1996-03-06 — — EP disclosed
WO-1994027980-A1 SUBSTITUTED OXAZOLYL COMPOUNDS FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1994-12-08 — — WO disclosed
Send feedback